RT-CGM has become an essential tool for diabetes management in older adults and now, CMS has expanded CGM coverage-allowing millions more people access to Dexcom RT-CGM. Dexcom G7 is now covered for all Medicare patients on insulin.* Even those Medicare beneficiaries who are not on insulin, but experience hypoglycemic events, may qualify for Dexcom CGM coverage.
During this webinar you will learn more about the impact of hypoglycemia in older adults along with the use of RT-CGM, including its features, benefits and clinical evidence that supported the new Medicare expanded CGM coverage. For older adults with diabetes, Dexcom RT-CGM is clinically proven to reduce hypoglycemia and improve overall glycemic outcomes.1-5 It can also provide valuable information to caregivers and healthcare providers about the individual’s glucose patterns, which can inform treatment decisions.
Join our webinar to hear about Dexcom G7: Now more of your patients can experience the life-changing benefits of Dexcom.
*Medicare covers Dexcom CGM for insulin-requiring patients who meet the Medicare coverage criteria. For a list of Medicare coverage criteria, visit the Centers for Medicare and Medicaid Services website. 1.Beck RW, et al. JAMA. 2017;317(4):371-378. 2. Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 3. Martens T, et al. JAMA. 2021;325(22):2262-2272. 4. Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 5. Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.